Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Continuous sequential boundaries for vaccine safety surveillance.

Li R, Stewart B, Weintraub E, McNeil MM.

Stat Med. 2014 Aug 30;33(19):3387-97. doi: 10.1002/sim.6161. Epub 2014 Apr 1.

PMID:
24691986
2.

A conditional maximized sequential probability ratio test for pharmacovigilance.

Li L, Kulldorff M.

Stat Med. 2010 Jan 30;29(2):284-95. doi: 10.1002/sim.3780.

PMID:
19941282
3.

Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons.

Li R, Stewart B, McNeil MM, Duffy J, Nelson J, Kawai AT, Baxter R, Belongia EA, Weintraub E.

Pharmacoepidemiol Drug Saf. 2016 Aug;25(8):928-34. doi: 10.1002/pds.3996. Epub 2016 Apr 1.

PMID:
27037540
4.

Combination measles-mumps-rubella-varicella vaccination and the risk of febrile seizure.

Top KA, MacDonald NE.

CMAJ. 2014 Aug 5;186(11):812-3. doi: 10.1503/cmaj.140778. Epub 2014 Jun 30. No abstract available.

5.

Concomitant administration of a bivalent Haemophilus influenzae type b-hepatitis B vaccine, measles-mumps-rubella vaccine and varicella vaccine: safety, tolerability and immunogenicity.

Hesley TM, Reisinger KS, Sullivan BJ, Jensen EH, Stasiorowski S, Meechan C, Chan CY, West DJ; HIB-HB VACCINE STUDY GROUP.

Pediatr Infect Dis J. 2004 Mar;23(3):240-5.

PMID:
15014300
6.

Real-time vaccine safety surveillance for the early detection of adverse events.

Lieu TA, Kulldorff M, Davis RL, Lewis EM, Weintraub E, Yih K, Yin R, Brown JS, Platt R; Vaccine Safety Datalink Rapid Cycle Analysis Team.

Med Care. 2007 Oct;45(10 Supl 2):S89-95.

PMID:
17909389
7.

Association rule mining in the US Vaccine Adverse Event Reporting System (VAERS).

Wei L, Scott J.

Pharmacoepidemiol Drug Saf. 2015 Sep;24(9):922-33. doi: 10.1002/pds.3797. Epub 2015 Jun 4.

PMID:
26045284
8.

Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures.

Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, Baxter R, Hambidge S, Nordin J, Naleway A, Belongia EA, Lieu T, Baggs J, Weintraub E; Vaccine Safety Datalink.

Pediatrics. 2010 Jul;126(1):e1-8. doi: 10.1542/peds.2010-0665. Epub 2010 Jun 29.

PMID:
20587679
9.

Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.

Nolan T, Bernstein DI, Block SL, Hilty M, Keyserling HL, Marchant C, Marshall H, Richmond P, Yogev R, Cordova J, Cho I, Mendelman PM; LAIV Study Group.

Pediatrics. 2008 Mar;121(3):508-16. doi: 10.1542/peds.2007-1064.

PMID:
18310199
10.

Simulation study comparing exposure matching with regression adjustment in an observational safety setting with group sequential monitoring.

Stratton KG, Cook AJ, Jackson LA, Nelson JC.

Stat Med. 2015 Mar 30;34(7):1117-33. doi: 10.1002/sim.6398. Epub 2014 Dec 15.

PMID:
25510526
11.

Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.

Tse A, Tseng HF, Greene SK, Vellozzi C, Lee GM; VSD Rapid Cycle Analysis Influenza Working Group.

Vaccine. 2012 Mar 2;30(11):2024-31. doi: 10.1016/j.vaccine.2012.01.027.

PMID:
22361304
12.

Safety of measles-containing vaccines in 1-year-old children.

Klein NP, Lewis E, Fireman B, Hambidge SJ, Naleway A, Nelson JC, Belongia EA, Yih WK, Nordin JD, Hechter RC, Weintraub E, Baxter R.

Pediatrics. 2015 Feb;135(2):e321-9. doi: 10.1542/peds.2014-1822. Epub 2015 Jan 5.

13.

Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine.

Daley MF, Yih WK, Glanz JM, Hambidge SJ, Narwaney KJ, Yin R, Li L, Nelson JC, Nordin JD, Klein NP, Jacobsen SJ, Weintraub E.

Vaccine. 2014 May 23;32(25):3019-24. doi: 10.1016/j.vaccine.2014.03.063. Epub 2014 Mar 31.

PMID:
24699471
14.

Monitoring vaccine safety using case series cumulative sum charts.

Musonda P, Hocine MN, Andrews NJ, Tubert-Bitter P, Farrington CP.

Vaccine. 2008 Oct 3;26(42):5358-67. doi: 10.1016/j.vaccine.2008.08.010. Epub 2008 Aug 22.

PMID:
18723063
15.

Simultaneous vaccination of Chinese applicants for a United States immigrant visa.

Hua L, Hongtao H, Shunqin W, Jinping G, Jiandong C, Zhaoliang L, Xinwen F.

Travel Med Infect Dis. 2008 May;6(3):130-6. doi: 10.1016/j.tmaid.2008.03.004.

PMID:
18486068
16.

Postlicensure epidemiology of childhood vaccination: the Danish experience.

Hviid A.

Expert Rev Vaccines. 2006 Oct;5(5):641-9. Review.

PMID:
17181438
17.

Validation of the French national health insurance information system as a tool in vaccine safety assessment: application to febrile convulsions after pediatric measles/mumps/rubella immunization.

Hanf M, Quantin C, Farrington P, Benzenine E, Hocine NM, Velten M, Tubert-Bitter P, Escolano S.

Vaccine. 2013 Dec 2;31(49):5856-62. doi: 10.1016/j.vaccine.2013.09.052. Epub 2013 Oct 14.

PMID:
24135575
18.

Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT.

Le Saux N, Barrowman NJ, Moore DL, Whiting S, Scheifele D, Halperin S; Canadian Paediatric Society/ Health Canada Immunization Monitoring Program-Active (IMPACT).

Pediatrics. 2003 Nov;112(5):e348.

PMID:
14595075
19.

Early detection of adverse drug events within population-based health networks: application of sequential testing methods.

Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R.

Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1275-84.

PMID:
17955500
20.

Febrile seizures and measles-mumps-rubella-varicella (MMRV) vaccine: what do primary care physicians think?

O'Leary ST, Suh CA, Marin M; Vaccine Policy Collaborative Initiative.

Vaccine. 2012 Nov 6;30(48):6731-3. doi: 10.1016/j.vaccine.2012.08.075. Epub 2012 Sep 10.

PMID:
22975026

Supplemental Content

Support Center